{"id":"https://genegraph.clinicalgenome.org/r/77a51e39-be3c-446e-b83c-4e80bbff9788v1.0","type":"EvidenceStrengthAssertion","dc:description":"SLC26A2 was first associated with autosomal recessive atelosteogenesis type 2 as early as 1996 (Hästbacka et al., PMID: 8571951). Clinical features of this disorder include rhizomelic limb shortening, hitchhiker thumbs, small chest, protuberant abdomen, cleft palate, and characteristic facial features (GeneReviews, Bonafé et al., 2014). However, radiographic analysis and histopathology are also important in arriving at a diagnosis. The majority of probands die after birth due to respiratory failure. At least 9 unique variants (including missense, splice site, nonsense, and frameshift variants as well as in-frame indels) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 7 probands in 6 publications (PMID: 8571951, 8931695, 9342225, 18708426, 16642506, 21077202). In addition, one proband from a publication without a PMID (Mattos et al. 2014) was included to reach a total score of 16 points. Variants in this gene segregated with disease in 3 additional family members. More evidence is available in the literature; however, the maximum score for genetic evidence has been reached. Of note, variants in this gene have also been shown to cause achondrogenesis type 1B, diastrophic dysplasia, and recessive multiple epiphyseal dysplasia, which comprise a spectrum of phenotypes (depending on level of residual sulfate transport) and have been definitively associated with SLC26A2. This gene-disease association is supported by expression studies and in vitro functional assays. In summary, SLC26A2 is definitively associated with autosomal recessive atelosteogenesis type 2. This curation was approved by the Skeletal Disorders Gene Curation Expert Panel (GCEP) on 7/14/2020.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/77a51e39-be3c-446e-b83c-4e80bbff9788","GCISnapshot":"https://genegraph.clinicalgenome.org/r/da79a651-9fc7-453e-a1c1-145771baa2f9","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/da79a651-9fc7-453e-a1c1-145771baa2f9_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2020-07-14T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/da79a651-9fc7-453e-a1c1-145771baa2f9_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2020-10-26T17:24:03.964Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da79a651-9fc7-453e-a1c1-145771baa2f9_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/38632e0b-018c-4bed-8390-1f21838438d9_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The p.Arg279Trp variant was awarded the full 0.5 points due to a functional assay in Karniski 2004 (PMID: 15294877).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/861ceb29-a4e0-426a-aa40-27dda6405b7a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","rdfs:label":"Hastbacka patient 1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"Patient 1 was a fetus diagnosed with AO2. It was the second affected fetus in this family.","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/38632e0b-018c-4bed-8390-1f21838438d9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","allele":[{"id":"https://genegraph.clinicalgenome.org/r/418b4dba-9580-44ca-95f3-7f53732c0ffe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.1724del (p.Lys575fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252988"}},{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.835C>T (p.Arg279Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252990"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/da79a651-9fc7-453e-a1c1-145771baa2f9_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11df3b74-3237-422b-8ef9-0ca3c3c05035_proband_segregation","type":"FamilyCosegregation","dc:description":"Not included as the LOD score is not high enough.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21077202","rdfs:label":"Dwyer et al. family","estimatedLodScore":1.7,"family":{"id":"https://genegraph.clinicalgenome.org/r/11df3b74-3237-422b-8ef9-0ca3c3c05035","type":"Family","rdfs:label":"Dwyer et al. family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/3db35e83-81fe-43c1-b924-e05679fc1b63","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21077202","rdfs:label":"Case 3","ageType":"AgeAtDeath","ageUnit":"Days","ageValue":12,"detectionMethod":"","phenotypes":["obo:HP_0003561","obo:HP_0001518","obo:HP_0000470","obo:HP_0002947","obo:HP_0000773","obo:HP_0001602","obo:HP_0000457","obo:HP_0001234","obo:HP_0001762","obo:HP_0001852","obo:HP_0040194","obo:HP_0001538","obo:HP_0001156","obo:HP_0000175","obo:HP_0000369","obo:HP_0005257","obo:HP_0009826","obo:HP_0001591","obo:HP_0000347"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/bcb53a65-96d2-402d-a555-5d4a7552c7a6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21077202","allele":[{"id":"https://genegraph.clinicalgenome.org/r/ccd8beb4-f184-4277-823b-7150cc6b0614","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.-26+2T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340160"}},{"id":"https://genegraph.clinicalgenome.org/r/15290e06-e7b2-460b-a435-da0b2d2c8d59","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.4(SLC26A2):c.145del (p.Arg49AspfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA563955676"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/3db35e83-81fe-43c1-b924-e05679fc1b63"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9271f085-5ebd-4f1a-bb73-882c8a0176a6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The p.Arg279Trp variant was awarded 0.5 points due to functional evidence in Karniski 2004 (PMID: 15294877).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/984cfdce-83eb-4e99-b7be-bbd3b718240a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8931695","rdfs:label":"Rossi 1996 patient 1","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":21,"detectionMethod":"","firstTestingMethod":"SSCP","phenotypes":"obo:HP_0009826","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/9271f085-5ebd-4f1a-bb73-882c8a0176a6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8931695","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e"},{"id":"https://genegraph.clinicalgenome.org/r/1dca2aa0-eaf4-43c2-a758-7f5babb8155d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.391del (p.Leu131fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252989"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c201fdb5-b2e1-4e5f-aa2f-cd8da4950187_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This variant was left at the default score due to a functional assay (in this paper) showing that the p.Thr512Lys variant causes impaired sulfate uptake.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2cc7f1a7-20a1-4d16-a516-bdc07657e563","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18708426","rdfs:label":"Bonafé proband","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0003022","obo:HP_0000946","obo:HP_0001776","obo:HP_0008857","obo:HP_0002983","obo:HP_0003026","obo:HP_0001538","obo:HP_0003015","obo:HP_0003063","obo:HP_0001156","obo:HP_0000347","obo:HP_0003038","obo:HP_0004599"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c201fdb5-b2e1-4e5f-aa2f-cd8da4950187_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18708426","allele":{"id":"https://genegraph.clinicalgenome.org/r/05b50578-afd8-4b15-b4fc-26dc9c4b5640","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.1535C>A (p.Thr512Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116649"}}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/71a7232d-c18b-46db-a029-006f1d613738_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Each missense variant was awarded 0.5 points due to functional evidence in Karniski 2001 and 2001 (PMID: 11448940, 15294877).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93ed1627-78dc-45fc-b420-00ed0f9388be","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","rdfs:label":"Hastbacka patient 3","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":2,"detectionMethod":"","firstTestingMethod":"PCR","phenotypeFreeText":"This patient was a term baby diagnosed with AO2. The patient survived for 2 months with intensive care, including ventilation.","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/71a7232d-c18b-46db-a029-006f1d613738_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","allele":[{"id":"https://genegraph.clinicalgenome.org/r/409bc7c7-1b0e-4ea4-b302-e9e2002ac791","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.764G>A (p.Gly255Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252992"}},{"id":"https://genegraph.clinicalgenome.org/r/1bcb8b32-913e-453b-87ef-9e0ce48b26d2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.2144C>T (p.Ala715Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252994"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2f7a6173-bd69-49cf-b7eb-2ea0f3b2a727_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Each missense variant was scored 0.5 points due to functional evidence in this paper and in Karniski 2001 (PMID: 11448940).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8408d933-b43d-48fe-96eb-6605625306d4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16642506","rdfs:label":"Maeda proband","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":19,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001234","obo:HP_0000774","obo:HP_0011314","obo:HP_0009815","obo:HP_0000256","obo:HP_0001762","obo:HP_0002984","obo:HP_0005033","obo:HP_0003063","obo:HP_0008479","obo:HP_0002867","obo:HP_0003026","obo:HP_0003097"],"previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2f7a6173-bd69-49cf-b7eb-2ea0f3b2a727_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16642506","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e"},{"id":"https://genegraph.clinicalgenome.org/r/783c92d4-c56d-4475-8ca4-964a81392ac3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.1987G>A (p.Gly663Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/550616"}}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/18e25997-6704-4a84-a596-8a6d90d19dcd_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Each missense variant was awarded 0.5 points due to functional evidence in Karniski 2001 and 2004 (PMID: 11448940, 15294877).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55cc1cc9-9c21-4d0e-bb7f-951dd7a21a3c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9342225","rdfs:label":"Rossi 1997 proband","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":22,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000926","obo:HP_0009826","obo:HP_0003026","obo:HP_0001234","obo:HP_0003063","obo:HP_0002866"],"previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/18e25997-6704-4a84-a596-8a6d90d19dcd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9342225","allele":[{"id":"https://genegraph.clinicalgenome.org/r/04feeafa-ce43-4ccb-aeec-4fd02f8d35e7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000112.3(SLC26A2):c.1273A>G (p.Asn425Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA259842"}},{"id":"https://genegraph.clinicalgenome.org/r/7d90b82b-8667-4156-a2cb-278cb5f8bc4e"}]}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/bcb53a65-96d2-402d-a555-5d4a7552c7a6_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3db35e83-81fe-43c1-b924-e05679fc1b63"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10},{"id":"https://genegraph.clinicalgenome.org/r/da79a651-9fc7-453e-a1c1-145771baa2f9_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da79a651-9fc7-453e-a1c1-145771baa2f9_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3cf2390a-dc27-4f9e-bbb8-6439a723dc44","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec247310-c43f-406d-89ec-f87dfd91fb82","type":"FunctionalAlteration","dc:description":"Sulfate uptake assays in skin fibroblasts from 3 patients with AO2 showed a defect in uptake of inorganic sulfate. Compared to controls and DTD patients, cells from AO2 patients showed decreased sulfate incorporation during proteoglycan synthesis (as measured by the ratio of 35S to 3H).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8571951","rdfs:label":"Sulfate uptake assay"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8f4e9621-ce0c-41cc-9235-51bdc2ec4f35","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/168b869a-80f9-491f-8656-4b5c1c7b10a0","type":"FunctionalAlteration","dc:description":"Fibroblasts from all 3 patients had reduced incorporation of sulfate into macromolecules.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8931695","rdfs:label":"Sulfate incorporation assay"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/da79a651-9fc7-453e-a1c1-145771baa2f9_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e6e39ba-38fb-4b22-8076-aa852836e073","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9937524-4ef1-4e83-8572-b201971266f9","type":"Finding","dc:description":"Decreased sulfate transport has been reported to be a mechanism for variants associated with AO2 and other disorders of the SLC26A2 spectrum (PMID: 15294877).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9575183","rdfs:label":"Sulfate uptake assay","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/de6f7adf-2b37-4776-bde5-0e72d37631af","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0c2ad09-2b3c-4089-9548-ece4618b0f1c","type":"Finding","dc:description":"Immunohistochemistry showed that Slc26a2 was expressed in the chondrocytes of freshly isolated mouse articular cartilage explants.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25373420","rdfs:label":"Expression in mouse articular cartilage","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bd4871c7-a186-4b05-ac17-2bda3656b4ba","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d2b3211-0558-4ca3-95fd-a2744c666c17","type":"Finding","dc:description":"In situ hybridization and immunostaining detected SLC26A2 mRNA in developing fetal hyaline cartilage and adult bronchial cartilage.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11457925","rdfs:label":"Expression in cartilage","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cb31b644-8e7d-413c-9194-7bfe85691bd7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dcbe2925-ec8a-4e19-9f22-0de2d0eec730","type":"Finding","dc:description":"In situ hybridization showed that Slc26a2 was expressed in the limbs, craniofacial regions, and lumbosacral spine of mouse embryos at day 14.5.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26077908","rdfs:label":"Expression in mouse limbs, skull and spine","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4}],"evidenceStrength":"Definitive","sequence":1381,"specifiedBy":"GeneValidityCriteria7","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/BMAORgNFPgE","type":"GeneValidityProposition","disease":"obo:MONDO_0009727","gene":"hgnc:10994","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_da79a651-9fc7-453e-a1c1-145771baa2f9-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}